-
Who are the 10 key players in the $226B spine biologics market?
The global spine biologics market is projected to grow at a 4.4 percent compound annual growth rate, from $226 billion in 2018 to $280 billion by 2023, according to a Market Data Forecast report. -
206 Ortho gets bio-inspired patent: 3 quick notes
Orthopedic company 206 Ortho secured a patent for a new biocompatible composite designed to repair load-bearing bone and resorb without leaving a trace. -
Emory Orthopaedics & Spine Center receives $13M to study stem cell osteoarthritis treatments: 4 notes
Atlanta-based Emory Orthopaedics & Spine Center earned a $13 million grant from The Marcus Foundation for a multicenter clinical trial to evaluate stem cell treatments for osteoarthritis. -
Bone Biologics raises $5.9M: 3 notes
Bone Biologics completed $5.9 million of financing. -
Viscogliosi Brothers to purchase Bioventus' BMP development program: 5 insights
Bioventus entered into a definitive agreement to divest its bone morphogenetic protein development program to a new Viscogliosi Brothers company. -
3 things to know about Ortho RTi
Ortho Regenerative Technologies is an orthopedic biotechnology company developing novel therapeutic tissue repair devices for sports medicine surgeries. -
23 developments in spine & orthopedic biologics research in 2018
Here are 23 study developments in spine and orthopedic biologics for 2018 so far: -
3 things to know about AlloSource
AlloSource is the world's largest processor of cellular bone allografts. -
Aziyo Biologics enters co-marketing agreement with SurGenTec for minimally invasive bone graft delivery: 3 insights
Aziyo Biologics agreed to provide its viable bone matrix product ViBone to medical device company SurGenTec for use with the GraftGun universal graft delivery system. -
Cerapedics closes $22M financing round: 3 takeaways
Cerapedics completed a $22 million financing round to accelerate commercialization of its i-FACTOR Peptide Enhanced Bone Graft for degenerative disc disease. -
17 major players in the global spine biologics market
The global spine biologics market is forecasted to grow at a 4.4 percent compound annual growth rate to exceed $2.6 billion by 2020, according to a Market Research Engine report. -
Dr. Chad Lavender performs ACL repair with bone marrow: 3 things to know
Huntington, W. Va.-based Marshall Orthopaedics surgeon Chad Lavender, MD, is now performing anterior cruciate ligament repair procedures using a patient's bone marrow. -
Stem cell therapy successfully repairs torn meniscus in case study: 4 findings
Adipose-derived autologous stem cell therapy may be used to successfully repair a meniscus injury, according to a study in the Journal of Medical Cases. -
5 new biologic device launches or releases in 2018
Here are five new biologic device launches or releases in 2018 so far: -
3 things to know about the NanoFuse Bioactive Matrix
NanoFUSE Biologics will attend the 2018 International Meeting on Advanced Spine Techniques in Los Angeles between July 11 and July 14. -
SpineMark enters strategic partnership with Regenexx to boost biologic options, patient volume: 4 key points
Global spine service company SpineMark partnered with Regenexx Corp. to refer candidates for surgery at the company's centers for excellence. -
NanoFuse Biologics adds orthobiologics executive: 3 insights
NanoFUSE Biologics appointed Archie Yamada as vice president of product business development. -
Connect Healthcare Collaboration selects Regenexx as solution to lower employers' orthopedic surgery costs
Connect Healthcare Collaboration will recommend Regenexx to its employer partners in order to offer alternatives to orthopedic surgery. -
Zimmer Biomet to terminate exclusive distribution agreement with BoneSupport: 5 things to know
Zimmer Biomet, the former U.S. exclusive distributor for BoneSupport, cancelled a majority of its Cerament Bone Void Filler orders for a three month period starting in June. -
Medtronic's Kyphon HV-R Bone Cement receives 2nd indication: 4 key points
The FDA awarded approval for a second indication of Medtronic's Kyphon HV-R Bone Cement.
Page 30 of 34